Bhanja virus

From WikiMD's WELLNESSPEDIA

Bhanja virus is a virus that belongs to the Bunyaviridae family and the Phlebovirus genus. It was first isolated in India in 1954 from a tick species known as Hyalomma marginatum. The virus is named after the location of its discovery, Bhanjanagar, in the Indian state of Odisha.

History[edit]

The Bhanja virus was first discovered in 1954 during a study on the arboviruses present in the Indian tick population. The virus was isolated from a Hyalomma marginatum tick in Bhanjanagar, Odisha. Since its discovery, the virus has been isolated in various parts of the world, including Europe, Africa, and Asia.

Virology[edit]

Bhanja virus is a member of the Bunyaviridae family, which is a large family of enveloped, RNA viruses. It belongs to the Phlebovirus genus, which includes other tick-borne viruses. The virus is spherical in shape and has a diameter of approximately 100 nanometers.

The virus has a tripartite, single-stranded RNA genome. The three segments are known as the Large (L), Medium (M), and Small (S) segments. The L segment encodes the RNA polymerase, the M segment encodes the glycoproteins, and the S segment encodes the nucleocapsid protein.

Transmission and Epidemiology[edit]

Bhanja virus is primarily transmitted through the bite of infected ticks, particularly Hyalomma marginatum. The virus has been found in various tick species across the world, indicating a wide geographic distribution.

Humans can become infected with Bhanja virus through the bite of an infected tick. However, human infections are rare and usually result in a mild, self-limiting illness. Symptoms can include fever, headache, and muscle pain.

Research[edit]

Research into Bhanja virus is ongoing, with scientists working to understand its transmission, epidemiology, and potential impact on human health. Despite its wide geographic distribution, the virus is not considered a major public health threat due to its low pathogenicity in humans.

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.